**What is already known about the topic?**

-   Phase of Illness, used for casemix classification for palliative care in Australia and now the United Kingdom, predicts resource use and has fair inter-rater reliability.

-   Its relationship to validated measures of clinical need has not been demonstrated.

**What this paper adds?**

-   The different phases of illness are characterised by differences in function, pain, other physical problems, psycho-spiritual problems and family and carer support needs.

-   Pain is worst in the unstable phase, family and carer support needs are greatest in the deteriorating phase and function is worst in the dying phase.

-   Phase of Illness has been used as a measure to reflect changing care needs and captures additional clinical information beyond the combination of Australia-modified Karnofsky Performance Scale (AKPS) and Palliative Care Problem Severity Scale (PCPSS).

**Implications for practice, theory or policy**

-   Phase of Illness can be used to inform clinical interventions, casemix-adjust quality measures and potentially to underpin value-based reimbursement mechanisms in palliative care.

-   Palliative care teams should be trained in using Phase of Illness and be incentivized to record it routinely across all settings.

Introduction {#section6-0269216317727157}
============

'Phase of Illness' is used in advanced illness to describe the distinct stages of an individual's illness according to the care needs of the individual, the family and the suitability of the current care plan to address these needs.^[@bibr1-0269216317727157]^ It was originally derived from work on casemix classification within palliative care in Australia and is a major determinant of resource use.^[@bibr2-0269216317727157]^

Patients are classified into one of five phases, outlined in [Table 1](#table1-0269216317727157){ref-type="table"}, with a new phase assigned whenever a clinical change requires patient and family re-assessment and modification of the existing care plan. Phase of Illness is (except for the dying and deceased phases) not reliant on stage of disease and prognosis, and patients may move between phases in any sequence.^[@bibr3-0269216317727157]^ Distinct characteristics of Phase of Illness are (1) its relationship with needs and resource use and (2) the individual and family as the unit of care. The term 'episode of care' is used to define the period of contact between a patient and a provider or team of providers that occurs in one setting, beginning with the first contact with the patient and ending at discharge or when the patient dies. One episode of care may comprise one, or multiple phases; mean number of phases per episode has been reported as 1.68 for inpatient care and 1.31 for community care.^[@bibr4-0269216317727157]^

###### 

Definitions of Phase of Illness, for use in palliative care/advanced illness.^[@bibr1-0269216317727157]^

![](10.1177_0269216317727157-table1)

  Phase of Illness   Patient in this phase when                                                                                                                                                                                                                                                                                                                                              Phase ends when
  ------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Stable             Patient's problems and symptoms are adequately controlled by the established plan of care and further interventions to maintain symptom control and quality of life have been planned and family/carer situation is relatively stable and no new issues are apparent.                                                                                                   The needs of the patient and/or family/carer increase, requiring changes to the existing plan of care.
  Unstable           An urgent change in the plan of care or emergency treatment is required because the patient experiences a new problem that was not anticipated in the existing plan of care and/or the patient experiences a rapid increase in the severity of a current problem and/or family/carer circumstances change suddenly impacting patient care.                              The new plan of care is in place, it has been reviewed and no further changes to the care plan are required. This does not necessarily mean that the symptom/crises has fully resolved but there is a clear diagnosis and plan of care (i.e. patient is stable or deteriorating) and/or death is likely within days (i.e. patient is now dying).
  Deteriorating      The care plan addresses anticipated needs, but requires periodic review, because the patient's overall functional status declines and the patient experiences a gradual worsening of existing problem(s) and/or the patient experiences a new, but anticipated, problem and/or the family/carer experiences gradual worsening distress that impacts the patient care.   Patient condition plateaus (i.e. patient is now stable) or an urgent change in the care plan or emergency treatment and/or family/carers experience a sudden change in their situation that impacts patient care, and urgent intervention is required (i.e. patient is now unstable) or death is likely within days (i.e. patient is now dying).
  Dying              Dying: death is likely within days.                                                                                                                                                                                                                                                                                                                                     Patient dies or patient condition changes and death is no longer likely within days (i.e. patient is now stable and/or deteriorating).
  Deceased           The patient has died; bereavement support provided to family/carers is documented in the deceased patient's clinical record.                                                                                                                                                                                                                                            Case is closed.

Phase of Illness was originally developed, through clinical consensus, as a key component of a casemix classification for palliative care.^[@bibr4-0269216317727157]^ Casemix classifications categorise patients into homogeneous groups of need and resource use on the basis of key predictor variables and, in addition to underpinning reimbursement systems within healthcare, provide a means of capturing and communicating patient care needs. In other areas of healthcare, especially within acute hospital-based specialties such as surgery and orthopaedics, diagnosis and interventions often form the basis of casemix classifications, as in the healthcare resource group system in England.^[@bibr5-0269216317727157]^ However, in palliative care, diagnosis is a poor predictor of need and resource use, a challenge common to some other areas of healthcare where improvements in quality of life and function are the goals of care (such as psychiatry, psycho-geriatrics and rehabilitation medicine).^[@bibr6-0269216317727157]^ Phase of Illness was thus developed in response to this challenge, as the key clinical variable within a casemix classification for palliative care in Australia.^[@bibr7-0269216317727157]^ The original definitions of the different phases have been reviewed in recent years with little clinical call for change.^[@bibr1-0269216317727157]^ Phase of Illness remains the basis of the most recent iteration of a casemix classification for palliative care in Australia and has recently been introduced in England in this capacity.^[@bibr8-0269216317727157],[@bibr9-0269216317727157]^

It is important to know how Phase of Illness behaves alongside other validated measures of symptoms and needs in palliative care. A recent study across 10 palliative care services in Australia reported fair inter-rater reliability and acceptability.^[@bibr1-0269216317727157]^ But there remains little published evidence on the association of Phase of Illness with other validated measures of clinical needs. In order to address this knowledge-gap, this study aims to

1.  Describe the distribution of (a) function, (b) pain, (c) other physical problems, (d) psycho-spiritual problems and (e) family and carer support needs, by Phase of Illness;

2.  Examine, using multinomial logistic regression, associations between these five domains and Phase of Illness.

Methods {#section7-0269216317727157}
=======

Setting and participants {#section8-0269216317727157}
------------------------

A secondary analysis was undertaken of individual patient-level data collected as part of routine clinical care between March 2012 and December 2013 from patients attending three palliative care services within the South East of England. These data were collected as part of a pilot data collection following recommendations by the independent Palliative Care Funding Review in England.^[@bibr10-0269216317727157]^ The hospital support service ('hospital') provides a specialist consultative and advisory palliative care service within one hospital site with approximately 1000 beds. The inpatient palliative care unit ('hospice') provides on-site, 24-h, multi-disciplinary specialist palliative care to individuals with life-limiting illness within a 48-bed facility. The community palliative care service ('community') provides specialist palliative care services to individuals within their primary place of residence, including advice and support to general palliative care providers in the community. All adult patients attending the services over the time period of data collection were eligible for inclusion in this analysis.

Data collection {#section9-0269216317727157}
---------------

For each participant, any member of the specialist palliative care team (i.e. doctors, registered nurses, nurse practitioners or social workers) with knowledge of the individual's clinical status made an assessment of Phase of Illness, along with function, pain, other physical problems, psycho-spiritual problems and family and carer support needs, at entry into the service and at each subsequent change in Phase of Illness (determined by the palliative care team member as defined above). Function was measured on an 11-point scale, the Australia-modified Karnofsky Performance Scale (AKPS), anchored between 0 (deceased) and 100 (best possible function), demonstrated to have good face and construct validity.^[@bibr11-0269216317727157]^ Pain, other physical problems, psycho-spiritual problems and family and carer support needs were all measured using items within the Palliative Care Problem Severity Scale (PCPSS), rated as 0 (absent), 1 (mild), 2 (moderate) and 3 (severe). These items have been demonstrated to have good inter-rater reliability for the measurement of these domains.^[@bibr12-0269216317727157]^ Clinical and demographic data were extracted from the clinical record. Trained administrators entered data into Microsoft Excel, which was then imported into SPSS version 22. The data were anonymised at point of extraction.

Statistical analysis {#section10-0269216317727157}
--------------------

All analyses were undertaken using SPSS version 22. Analysis was restricted to the first phase within an episode of care. Where an individual had more than one episode of care, the first episode of care within the time period of analysis was used. This approach was adopted to satisfy the assumption of independence of observations necessary for the analyses.

Sample characteristics were described using mean and standard deviation (SD) for continuous variables, and frequencies and percentages for categorical variables. Function, pain, other physical problems, psycho-spiritual problems and family and carer support needs were treated as continuous variables, and described using the mean and 95% confidence intervals (CIs). Phase of Illness was treated as a categorical variable. Comparison of AKPS and items on the PCPSS across Phase of Illness was undertaken using one-way analysis of variance (ANOVA) where assumptions were met (or Welch's ANOVA in the case of failure to meet the assumption of homogeneity of variance). Post hoc pairwise comparisons were undertaken using Tukey's honest significant difference (HSD) test or Games Howell test as appropriate, accounting for multiple testing. A multinomial regression was then undertaken with Phase of Illness as the dependent variable. AKPS and items on PCPSS significantly associated with Phase of Illness in the univariate analysis were entered into the model in one block as main effects. We hypothesised that symptom burden would be highest in the unstable phase. We therefore chose to present the analysis using the unstable phase as the reference category, to enable assessment of differences between this category and the other categories of Phase of Illness.

Ethical approval {#section11-0269216317727157}
----------------

The study used data that were fully anonymised and therefore did not require approval from a research ethics committee in line with King's College London's Research Ethics Committee procedures. The protocol for data extraction and analysis was approved by Caldicott Guardians within the participating organisations before commencement of the project.

Results {#section12-0269216317727157}
=======

Sample characteristics {#section13-0269216317727157}
----------------------

The initial sample comprised 1317 individuals, who experienced 2354 phases of illness, within 1578 episodes of care. The first phase within the first episode of care for each of these 1317 individuals was used for the analysis; this consisted of 241 stable phases, 618 unstable phases, 336 deteriorating phases and 122 dying phases. [Table 2](#table2-0269216317727157){ref-type="table"} outlines the sample characteristics. The mean age of the sample was 72.9 (SD ± 14.1 years). Fifty-one percent were female. Seventy-one percent were based in the community, 15.2% in the hospice and 13.7% in the hospital at the time of assessment. Seventy-five percent of the sample had a primary diagnosis of cancer.

###### 

Clinical and baseline characteristics (*n* = 1317).

![](10.1177_0269216317727157-table2)

  Characteristics                          
  ---------------------------------------- -------------
  Age, mean ± SD, years                    72.9 ± 14.1
  Gender, *n* (%)                          
   Male                                    664 (49.5)
   Female                                  652 (50.5)
   Missing                                 1 (0.0)
  Care setting, *n* (%)                    
   Home                                    936 (71.1)
   Hospice                                 200 (15.2)
   Hospital                                181 (13.7)
  Diagnosis, *n* (%)                       
  *Cancer*                                 
   Gastrointestinal (including pancreas)   267 (20.2)
   Lung                                    202 (15.3)
   Genitourinary                           189 (14.4)
   Breast                                  91 (6.9)
   Haematological                          68 (5.2)
   Brain                                   41 (3.1)
   Head and neck                           25 (1.9)
   Other cancer                            109 (8.3)
  *Non-cancer*                             
   Chronic obstructive pulmonary disease   52 (3.9)
   Dementia                                45 (3.4)
   Neurological                            41 (3.1)
   Cardiac failure                         41 (3.0)
   Chronic renal failure                   26 (2.0)
   Liver failure                           8 (0.6)
   Other non-cancer conditions             113 (8.7)

Level of palliative care need by Phase of Illness {#section14-0269216317727157}
-------------------------------------------------

Function, pain, other physical problems, psycho-spiritual problems and family and carer support needs varied significantly by Phase of Illness, as reported in [Table 3](#table3-0269216317727157){ref-type="table"} and depicted in [Figure 1](#fig1-0269216317727157){ref-type="fig"}. Function was highest in the stable phase, lowest in the dying phase and higher in the unstable phase than the deteriorating phase; the difference in function was significant across all pairwise comparisons (at *p* \< 0.05). Pain, other physical problems and psycho-spiritual problems were all significantly higher in the unstable and deteriorating phases than the stable and dying phases (at *p* \< 0.05), with higher pain additionally discriminating the unstable from the deteriorating phase (*p* \< 0.05). Family and carer support needs did not differ significantly between the unstable, deteriorating and dying phases, but in all three phases were significantly higher than in the stable phase (at *p* \< 0.05).

###### 

Mean level of function, pain, other physical problems, family and carer support needs and psycho-spiritual problems by Phase of Illness.

![](10.1177_0269216317727157-table3)

                  Function^[a](#table-fn1-0269216317727157){ref-type="table-fn"}^ (*n* = 1305)   Pain^[b](#table-fn2-0269216317727157){ref-type="table-fn"}^ (*n* = 1261)   Other physical problems^[c](#table-fn3-0269216317727157){ref-type="table-fn"}^ (*n* = 1260)   Psycho-spiritual problems^[d](#table-fn4-0269216317727157){ref-type="table-fn"}^ (*n* = 1259)   Family and carer support needs^[e](#table-fn5-0269216317727157){ref-type="table-fn"}^ (*n* = 1259)
  --------------- ------------------------------------------------------------------------------ -------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  Stable          65.9 (63.4--68.3)                                                              0.82 (0.72--0.92)                                                          1.29 (1.19--1.38)                                                                             1.12 (1.02--1.22)                                                                               1.08 (0.98--1.18)
  Unstable        50.2 (48.8--51.6)                                                              1.43 (1.36--1.51)                                                          1.87 (1.81--1.93)                                                                             1.56 (1.49--1.63)                                                                               1.64 (1.57--1.71)
  Deteriorating   42.9 (41.0--44.9)                                                              1.23 (1.13--1.33)                                                          1.92 (1.83--2.00)                                                                             1.53 (1.44--1.62)                                                                               1.78 (1.69--1.87)
  Dying           16.6 (15.3--17.8)                                                              0.94 (0.77--1.11)                                                          1.62 (1.45--1.79)                                                                             0.97 (0.81--1.14)                                                                               1.61 (1.47--1.77)

Difference in mean function by Phase of Illness statistically significant by one-way ANOVA (Welch's *F*(3, 546.040) = 656.287, *p* \< 0.001). Post hoc pairwise comparisons (Games Howell test) demonstrated statistically significant difference in the level of function for all pairwise comparisons (*p* \< 0.05).

Difference in mean pain by Phase of Illness statistically significant by one-way ANOVA (Welch's *F*(3, 409.635) = 34.902, *p* \< 0.001). Post hoc comparisons (Games Howell test) demonstrated statistically significant difference in all pairwise comparisons (*p* \< 0.05) except between the stable and the dying phases (*p* = 0.619).

Difference in mean other physical problems by Phase of Illness statistically significant by one-way ANOVA (Welch's *F*(3, 390.481) = 39.930, *p* \< 0.001). Post hoc comparisons (Games Howell test) demonstrated statistically significant difference in all pairwise comparisons (*p* \< 0.05) except between the unstable and the deteriorating phases (*p* = 0.766).

Difference in mean psycho-spiritual problems by Phase of Illness statistically significant by one-way ANOVA (Welch's *F*(3, 403.815) = 28.356, *p* \< 0.001). Post hoc pairwise comparisons (Games Howell test) demonstrated statistically significant difference in the level of psycho-spiritual problems for all pairwise comparisons (*p* \< 0.05) except between the unstable and the deteriorating phases (*p* = 0.979) and the stable and the dying phases (*p* = 0.431).

Difference in mean family and carer support needs by Phase of Illness statistically significant by one-way ANOVA (Welch's *F*(3, 405.727) = 38.778, *p* \< 0.001). Post hoc pairwise comparisons (Games Howell test) demonstrated statistically significant difference in family and carer support needs between the stable phase and all other phases (*p* \< 0.05), but no other statistically significant differences (*p* \< 0.05).

![Mean level of (a) function, (b) pain, (c) other physical problems, (d) psycho-spiritual problems and (e) family and carer support needs by Phase of Illness.\
Reports are based on the analysis of available data: (a) 1305 phases, (b) 1261 phases, (c) 1260 phases, (d) 1259 phases and (e) 1259 phases (*n* = 1317). Figures within each bar denote mean value for corresponding Phase of Illness. Error bars denote 95% confidence interval around the mean.](10.1177_0269216317727157-fig1){#fig1-0269216317727157}

Multinomial logistic regression {#section15-0269216317727157}
-------------------------------

According to the procedure outlined in the 'Methods' section, a multinomial logistic regression model was fitted to the data, with 'Phase of Illness' as the dependent variable, and AKPS and the four PCPSS items entered as independent variables ([Table 4](#table4-0269216317727157){ref-type="table"}). A model containing all five variables provided a good overall fit to the data (Pearson's *χ*^2^ = 1516.796, *df* = 1779, *p* = 1.000) and was significantly better than a constant-only model (*χ*^2^ = 741.034, *df* = 15, *p* \< 0.005). Function (*χ*^2^ = 478.999, *df* = 3, *p* \< 0.005), pain (*χ*^2^ = 47.521, *df* = 3, *p* \< 0.005), other physical problems (*χ*^2^ = 24.369, *df* = 3, *p* \< 0.005) and family and carer support needs (*χ*^2^ = 21.435, *df* = 3, *p* \< 0.005) all made a significant contribution to the model, with function most strongly associated with Phase of Illness. Only the psycho-spiritual problem score, after controlling for all other variables in the model, was not associated with Phase of Illness (*χ*^2^ = 2.940, *df* = 3, *p* = 0.401). Forty-nine percent of the variance in Phase of Illness was explained by measures of function, pain, other physical problems and family and carer support needs (Nagelkerke's pseudo *R*^2^ = 0.488).

###### 

Multinomial logistic regression of Phase of Illness (dependent variable) using function, pain, other physical problems, psycho-spiritual problems and family and carer support needs as independent variables, based on analysis of 1252 admission phases -- unstable phase as the reference phase.

![](10.1177_0269216317727157-table4)

                     Function            Pain                Other physical problems   Psycho-spiritual problems   Family and carer support needs
  ------------------ ------------------- ------------------- ------------------------- --------------------------- --------------------------------
  *Unstable*                                                                                                       
  Stable vs          1.44 (1.30--1.59)   0.51 (0.41--0.63)   0.57 (0.45--0.73)         0.87 (0.68--1.11)           0.68 (0.54--0.85)
  Deteriorating vs   0.81 (0.75--0.88)   0.77 (0.66--0.90)   1.03 (0.85--1.26)         0.94 (0.77--1.14)           1.23 (1.01--1.49)
  Dying vs           0.13 (0.08--0.19)   0.73 (0.53--0.99)   1.10 (0.77--1.57)         0.78 (0.55--1.11)           1.16 (0.83--1.61)

Data are based on the analysis of 1252 complete cases due to missing data on 65 cases. Model *χ*^2^ = 741.034, *df* = 15, *p* \< 0.005; Pearson's *χ*^2^ = 1516.796, *df* = 1779, *p* = 1.000; Nagelkerke's pseudo *R*^2^ = 0.488. Numbers indicate odds ratios (95% confidence intervals in brackets) for the association between the reference phase (italics) and the corresponding comparison phase.

[Table 4](#table4-0269216317727157){ref-type="table"} reports the odds ratios (ORs) for the association of AKPS and the four PCPSS items with Phase of Illness, with unstable phase as the reference category. The results are consistent with the univariate analysis, although with some exceptions. In the multivariate analysis, other physical problems were higher in the dying phase than both the deteriorating phase and the unstable phase, and the differences between these three phases did not reach statistical significance in this additional analysis. Family and carer support needs, in addition to being lower in the stable phase as compared to all other phases, consistent with the univariate analysis, were also significantly higher in the deteriorating phase than the unstable phase (OR (deteriorating vs unstable) = 1.23 (95% CI = 1.01−1.49)). In additional analyses, the difference in family and carer support needs between the deteriorating and unstable phases reached significance after adjustment for pain alone, significantly higher in the unstable phase, (OR (deteriorating vs unstable) = 1.25 (1.06--1.48), *p* = 0.007) and retained significance after adjusting for function, significantly lower in the deteriorating phase (OR (deteriorating vs unstable) = 1.20 (1.01--1.42), *p* = 0.034).

Discussion {#section16-0269216317727157}
==========

Main findings {#section17-0269216317727157}
-------------

In this study, we have described the significant differences in palliative care needs (as represented by measures of function, pain, other physical problems, psycho-spiritual problems and family and carer support needs) according to Phase of Illness. The variance in Phase of Illness was not accounted for entirely by AKPS and the selected items on the PCPSS; however, demonstrating that Phase of Illness captures more than the combination of these measures. These findings underpin the value of Phase of Illness in clinical practice as a measure of overall clinical need, and potentially as a determinant of resource use to meet those needs.

Considering the characteristics of the individual phases, these were consistent with the definitions outlined in [Table 1](#table1-0269216317727157){ref-type="table"}. Thus, the stable phase was differentiated from all other phases by higher function, lower other physical problems and lesser family and carer support needs. Furthermore, a lower pain level distinguished the stable phase from all except the dying phase. The unstable phase was discriminated from all other phases by a higher level of pain. A lower level of function distinguished the deteriorating phase from the stable and unstable phases, and the dying phase from all other phases. These results, while largely anticipated, illuminate the constructs used by healthcare providers when assigning Phase of Illness and serve to illustrate that Phase of Illness has clinically meaningful relationships with validated measures of function and problem severity.

A number of findings deserve further consideration. While psycho-spiritual problems varied significantly with Phase of Illness in the univariate analysis, they were not associated with Phase of Illness in the multivariate analysis. This may reflect the limitation of a 4-point scale to sufficiently discriminate between higher and lower levels of psycho-spiritual problems. The PCPSS has demonstrated good inter-rater reliability but it is yet to undergo further validation.^[@bibr12-0269216317727157]^ An alternate possibility, however, is that psycho-spiritual problems are addressed over longer time periods than a single phase, or may be less likely to trigger a change in care plan, and hence Phase of Illness. Psychological and emotional support has been incorporated within sets of quality indicators for palliative care and the possibility that such symptoms, of themselves, do not trigger a change in the plan of care and Phase of Illness, is of concern and requires further investigation.^[@bibr13-0269216317727157],[@bibr14-0269216317727157]^

The finding that family and carer support needs were significantly greater in the deteriorating phase than the unstable phase in the multivariate analysis was of further interest. Pain (highest in the unstable phase) has been demonstrated to be positively associated with caregiver burden.^[@bibr15-0269216317727157]^ The difference in family and carer support needs between the deteriorating and unstable phases reached significance after adjustment for pain alone. Reduced function, a feature of the deteriorating phase, has been associated with increased caregiver burden.^[@bibr16-0269216317727157],[@bibr17-0269216317727157]^ However, the increase in family and carer support needs in the deteriorating phase compared to the unstable phase retained significance after adjusting for reduced function suggesting there are other factors -- in addition to reduced function -- driving the higher family and carer support needs associated with the deteriorating phase. Of note, we did not explore the role of place of care as a driver of family and carer support needs. Place of care is conceivably associated with both Phase of Illness and family and carer support needs, and was not adjusted for in the analysis. Future studies should focus on understanding the role of place of care and other potential factors in mediating increased family and carer support needs in the deteriorating phase.

Finally, it is of interest that the combination of PCPSS and AKPS did not fully account for the variation in Phase of Illness (accounting for 49% by Nagelkerke's pseudo *R*^2^). In making the determination of Phase of Illness, this suggests that healthcare providers are taking considerations beyond the combination of AKPS and PCPSS into account. In this sense, Phase of Illness can be considered to capture clinical information in addition to the combination of these instruments. We examined only the relationship between the absolute values on the PCPSS, AKPS and Phase of Illness. It is conceivable that change in these dimensions is a greater determinant of Phase of Illness than absolute values.

Strengths and limitations {#section18-0269216317727157}
-------------------------

Understanding the relationship between Phase of Illness and existing validated measures of need in palliative care is important and valuable. Phase of Illness already forms the basis of the casemix classification in operation in Australia as well as the newly developed casemix classification for specialist palliative care within England, which is currently undergoing evaluation.^[@bibr2-0269216317727157],[@bibr18-0269216317727157]^ A considerable strength of the study was the successful use of routinely collected individual patient-level data to answer the research question, an approach that is both economical and facilitates research on a large sample.^[@bibr19-0269216317727157]^ The analysis of data from a large number of patients, with a range of diagnoses, in a variety of settings, serves furthermore to enhance the generalisability of the study's findings.

The study's limitations merit further consideration. First, while the use of routinely collected data has its strengths (described above), there are also a number of limitations, specifically constraints in terms of the range of variables measured, the consistency and quality of data recording, and the instruments used. In particular, pain, other physical problems, psycho-spiritual problems and family and carer support needs were all measured using the PCPSS. While this measure is yet to undergo formal validation, it has good inter-rater reliability and has been used extensively in the Palliative Care Outcomes Collaborative, a national initiative in Australia to collate and compare patient-centred outcomes among palliative care services.^[@bibr3-0269216317727157],[@bibr12-0269216317727157]^ However, the four 4-point subscales may be limited in scope or sensitivity to capture the full range of problems experienced by this population, which could account for some of the unexplained variation in Phase of Illness in the multivariate analysis. Other instruments, such as the Palliative care Outcome Scale or the Edmonton Symptom Assessment Scale, could be considered in the collection of patient-reported outcomes.^[@bibr20-0269216317727157]^ A further limitation of this study is the risk of sampling bias. The study sample is broadly representative of patients receiving palliative care based on gender, age and diagnosis; however, lack of data on individuals not included and reasons for exclusion limits our evaluation of sample bias.^[@bibr21-0269216317727157]^ Future studies relying on the use of routinely collected data would be strengthened by characterisation of all eligible individuals within the service over the time period of analysis, independent of their inclusion in the final sample.

Conclusion {#section19-0269216317727157}
==========

This study, to our knowledge, is the first to examine the association between Phase of Illness and validated measures of palliative care need, including function, pain, other physical problems, psycho-spiritual problems and family and carer support needs. The findings are of great importance in providing an understanding of the metrics used by healthcare providers to inform Phase of Illness and in characterising the nature of the different phases. Furthermore, they provide necessary and timely evidence to support the use of Phase of Illness as a measure of need within palliative care.
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